Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538925 · ClinicalTrials.gov registry record · Phase 2
Building Sentences With Preschoolers Who Use AAC
A Phase 2 study, sponsored by University of Central Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT03538925: Completed Phase 2 study, sponsored by University of Central Florida.
NCT03538925 is a Phase 2 study that has completed, run by University of Central Florida. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538925, a Phase 2 study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The focus of this investigation is to compare the effectiveness of the AAC Generative Language Intervention approach to an AAC Standard of Care condition on preschool sentence productions. All children will use existing AAC iPad applications.
Primary Outcome
Aided AAC sentence length measured in morphemes
Interventions
- BEHAVIORAL AAC Generative Language Intervention
- BEHAVIORAL Standard of Care / Business as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 2 |
What the finished NCT03538925 record still lists
NCT03538925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which AAC Generative Language Intervention is the first listed.
NCT03538925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03538925 about?
NCT03538925 is a clinical study titled "Building Sentences With Preschoolers Who Use AAC". The focus of this investigation is to compare the effectiveness of the AAC Generative Language Intervention approach to an AAC Standard of Care condition on preschool sentence productions. All children will use existing AAC iPad applications.
What is the current status of trial NCT03538925?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2018-05-11. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03538925?
The interventions under investigation include: AAC Generative Language Intervention (BEHAVIORAL), Standard of Care / Business as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT03538925?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03538925's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI